Capital Asset Advisory Services LLC Abbott Laboratories Transaction History

Capital Asset Advisory Services LLC

$2.01 Billion
Q3 2024

A detailed history of Capital Asset Advisory Services LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Capital Asset Advisory Services LLC holds 28,748 shares of ABT stock, worth $3.33 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

28,748

Previous 27,041 6.31%

Holding current value

$3.33 Million

Previous $2.81 Million 16.66%

% of portfolio

0.16%

Previous 0.15%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$100.07 - $118.13 $170,819 - $201,647	1,707 Added 6.31%	28,748 $3.28 Million
Q2 2024 Jul 24, 2024	BUY	$100.73 - $112.44 $264,718 - $295,492	2,628 Added 10.76%	27,041 $2.81 Million
Q1 2024 Apr 16, 2024	BUY	$109.52 - $120.96 $237,329 - $262,120	2,167 Added 9.74%	24,413 $2.77 Million
Q4 2023 Jan 09, 2024	BUY	$90.19 - $110.4 $190,120 - $232,723	2,108 Added 10.47%	22,246 $2.45 Million
Q3 2023 Oct 18, 2023	BUY	$95.53 - $114.62 $310,759 - $372,858	3,253 Added 19.27%	20,138 $1.95 Million
Q2 2023 Aug 02, 2023	BUY	$100.78 - $112.29 $114,788 - $127,898	1,139 Added 7.23%	16,885 $1.84 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $108,192 - $127,349	1,117 Added 7.64%	15,746 $1.59 Million
Q4 2022 Mar 08, 2023	BUY	$95.06 - $111.52 $250,102 - $293,409	2,631 Added 21.93%	14,629 $1.61 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $483,316 - $559,589	4,995 Added 71.33%	11,998 $1.16 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $122,075 - $147,550	1,196 Added 20.6%	7,003 $761,000
Q1 2022 Apr 29, 2022	BUY	$114.02 - $139.04 $6,043 - $7,369	53 Added 0.92%	5,807 $687,000
Q4 2021 Feb 04, 2022	BUY	$115.53 - $141.46 $10,513 - $12,872	91 Added 1.61%	5,754 $810,000
Q3 2021 Oct 14, 2021	SELL	$116.66 - $129.06 $62,996 - $69,692	-540 Reduced 8.71%	5,663 $669,000
Q2 2021 Aug 06, 2021	SELL	$105.79 - $124.53 $117,532 - $138,352	-1,111 Reduced 15.19%	6,203 $719,000
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $796,055 - $937,874	7,314 New	7,314 $876,000
Q3 2020 Nov 18, 2020	SELL	$91.64 - $111.29 $663,840 - $806,184	-7,244 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $12,480 - $15,974	163 Added 2.3%	7,244 $720,000
Q1 2020 May 18, 2020	SELL	$62.82 - $91.86 $45,418 - $66,414	-723 Reduced 9.26%	7,081 $655,000
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $611,121 - $680,321	7,784 Added 38920.0%	7,804 $699,000
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $358,869 - $399,505	-4,571 Reduced 99.56%	20 $682,000
Q3 2019 Oct 10, 2019	SELL	$81.84 - $88.74 $4,092 - $4,437	-50 Reduced 1.08%	4,591 $384,000
Q2 2019 Jul 15, 2019	SELL	$72.88 - $85.0 $3,133 - $3,655	-43 Reduced 0.92%	4,641 $390,000
Q4 2018 Jan 31, 2019	BUY	$65.56 - $74.27 $1,311 - $1,485	20 Added 0.43%	4,684 $339,000
Q3 2018 Jan 31, 2019	BUY	$60.81 - $73.36 $43,175 - $52,085	710 Added 17.96%	4,664 $342,000
Q2 2018 Jul 11, 2018	BUY	$57.57 - $63.54 $227,631 - $251,237	3,954 New	3,954 $241,000

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Asset Advisory Services LLC with notifications on news.

Account

Capital Asset Advisory Services LLC Abbott Laboratories Transaction History